Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality.

Teh SH, Christein J, Donohue J, Que F, Kendrick M, Farnell M, Cha S, Kamath P, Kim R, Nagorney DM.

J Gastrointest Surg. 2005 Dec;9(9):1207-15; discussion 1215.

PMID:
16332475
2.

Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.

Teh SH, Sheppard BC, Schwartz J, Orloff SL.

Am J Surg. 2008 May;195(5):697-701. doi: 10.1016/j.amjsurg.2007.05.054.

PMID:
18367132
3.

Perioperative risk assessment for hepatocellular carcinoma by using the MELD score.

Delis SG, Bakoyiannis A, Dervenis C, Tassopoulos N.

J Gastrointest Surg. 2009 Dec;13(12):2268-75. doi: 10.1007/s11605-009-0977-5. Epub 2009 Aug 7.

PMID:
19662460
4.

Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?

Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J.

Ann Surg. 2002 Nov;236(5):602-11.

5.

Is portal hypertension a contraindication to hepatic resection?

Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, Ramacciato G, Grazi GL, Pinna AD.

Ann Surg. 2009 Dec;250(6):922-8. doi: 10.1097/SLA.0b013e3181b977a5.

PMID:
19855258
6.

Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score.

Hsu KY, Chau GY, Lui WY, Tsay SH, King KL, Wu CW.

World J Surg. 2009 Nov;33(11):2412-9. doi: 10.1007/s00268-009-0202-4.

PMID:
19756859
7.
8.

Comparison of hepatocellular carcinoma with cirrhosis patients undergoing hepatic resection between hepatitis B and C infection.

Shiba H, Ishida Y, Fujiwara Y, Wakiyama S, Gocho T, Ito R, lida T, Suzuki F, Furukawa K, Haruki K, Misawa T, Yanaga K.

Hepatogastroenterology. 2013 Oct;60(127):1746-8.

PMID:
24634946
9.

Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis.

Yeh CN, Chen MF, Lee WC, Jeng LB.

J Surg Oncol. 2002 Dec;81(4):195-202. Review.

PMID:
12451624
10.

[Hepatic resections for hepatocellular carcinoma and cirrhosis].

Frangov T, Gań≠darski R, Vasilev S, Mladenov L.

Khirurgiia (Sofiia). 2002;58(1):8-10. Bulgarian.

PMID:
12515026
11.

Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis.

Nagasue N, Kohno H, Tachibana M, Yamanoi A, Ohmori H, El-Assal ON.

Ann Surg. 1999 Jan;229(1):84-90.

12.

Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.

Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J.

Hepatogastroenterology. 2002 Mar-Apr;49(44):518-23.

PMID:
11995486
13.

Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.

Dahiya D, Wu TJ, Lee CF, Chan KM, Lee WC, Chen MF.

Surgery. 2010 May;147(5):676-85. doi: 10.1016/j.surg.2009.10.043. Epub 2009 Dec 11.

PMID:
20004441
14.

Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables.

Cescon M, Cucchetti A, Grazi GL, Ferrero A, Viganò L, Ercolani G, Zanello M, Ravaioli M, Capussotti L, Pinna AD.

Arch Surg. 2009 Jan;144(1):57-63; discussion 63. doi: 10.1001/archsurg.2008.522.

PMID:
19153326
15.

[Hepatic resection for hepatocarcinoma in the cirrhotic patient].

Chiappa A, Zbar AP, Bertani E, Biella F, Staudacher C.

Chir Ital. 1999 Sep-Oct;51(5):345-54. Italian.

PMID:
10738607
17.

Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score.

Vitale A, Huo TL, Cucchetti A, Lee YH, Volk M, Frigo AC, Cescon M, Tuci F, Pinna AD, Cillo U.

Ann Surg Oncol. 2015;22(6):1901-7. doi: 10.1245/s10434-014-4099-2. Epub 2014 Sep 19.

PMID:
25234023
18.
19.

Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times.

Squires MH 3rd, Hanish SI, Fisher SB, Garrett C, Kooby DA, Sarmiento JM, Cardona K, Adams AB, Russell MC, Magliocca JF, Knechtle SJ, Staley CA 3rd, Maithel SK.

J Surg Oncol. 2014 May;109(6):533-41. doi: 10.1002/jso.23531. Epub 2013 Dec 17.

20.

Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study.

Ruzzenente A, Guglielmi A, Sandri M, Campagnaro T, Valdegamberi A, Conci S, Bagante F, Turcato G, D'Onofrio M, Iacono C.

J Gastrointest Surg. 2012 Feb;16(2):301-11; discussion 311. doi: 10.1007/s11605-011-1745-x. Epub 2011 Nov 18.

PMID:
22095524

Supplemental Content

Support Center